S&P futures are down 0.9% in Tuesday morning trading after US equities finished mostly higher, but off best levels in the prior session.
Oil flat, gold up and Bitcoin (BTC) down.
Here are some of today’s trending stocks:
Dave & Buster's Entertainment Inc (NASDAQ: PLAY)
Dave & Buster's Entertainment Inc (NASDAQ: PLAY) reported its Q1 earnings today.
PLAY shares are up 7.4% in pre-market trading after rising 4.6% in yesterday’s session.
Dave & Buster's is an American restaurant and entertainment business headquartered in Dallas. Each Dave & Buster's has a full-service restaurant and a video arcade.
Q1 Highlights
Revenue: 451.1m (up 24.1% from Q1 2019)
Net income: $67m ($1.35 per diluted share)
Adjusted EBITDA: $143.2m (up 45.9% from Q1 2019)
Cash: $139.1m
Liquidity available: $492.5m
Kevin Sheehan, Dave & Buster’s Board Chair and Interim CEO said:
We set records for revenue, net income and Adjusted EBITDA in the first quarter indicating a return to a normalized operating environment. We are excited about the trajectory of our business and particularly the next few months as we begin our “Summer of Games” roll-out that we hope will drive even more visitation to our stores.
As demonstrated by our first quarter results, our teams continue to execute on our initiatives to drive organic growth, improve profitability, and produce significant cash flow from the business.
Kohl's Corporation (NYSE: KSS)
Kohl's Corp (NYSE: KSS) share price is up 10% after confirming it is in takeover negotiations with Franchise Group over a $60 per share acquisition proposal. Rumors of a potential takeover have been circulating for some time as business has suffered under the shadow of COVID.
Kohl’s CEO expects business to improve as the year progresses. With the rollout of 400 additional Sephora stores, it hopes to benefit in the second half of 2022.
Over the past year, Kohl's Corporation (KSS) has traded between $34.64 and $64.38. Therefore, the $60 offer is closer to its 52-week high.
United Natural Foods Inc (NYSE: UNFI)
United Natural Foods Inc (NYSE: UNFI) is up 7% in pre-market trading. The company reported financial results for Q3 of fiscal 2022 (13 weeks) ended April 30, 2022.
Q3 Highlights
Net sales: $7.2bn (up 9.2%)
Net income: $67m (up 39.6%)
EPS: $1.10 (up 37.5%)
Adjusted EBITDA: $196m (up 5.9%)
Refinances and upsizes revolving credit facility by $500m with June 2027 maturity date
Sandy Douglas, UNFI Chief Executive Officer, said:
Our third quarter performance further demonstrates UNFI’s agility and its focus on servicing customers despite a challenging operating environment. It’s apparent that our Fuel the Future strategy is working and beginning to benefit our customers.
As we look towards a successful end to our fiscal year, we continue to make progress in simplifying our business and focusing resources on the most important areas that create value for our customers, suppliers, and shareholders.
Buzzfeed Inc (NASDAQ: BZFD)
Buzzfeed Inc (NASDAQ: BZFD) share price is rebounding 11% after crashing around 40% on Monday. The company’s market value has dropped from its June IPO of $1.5bn to around $300m.
Buzzfeed went public via a highly anticipated SPAC merger, and it appears the lock-up agreement recently expired allowing many insiders to sell their shares.
Over the past year, Buzzfeed Inc (BZFD) has traded between $2.22 and $14.77.
In March, nearly 80 former and current employees of BuzzFeed accused the company in complaints of denying its workers the chance to sell their shares at a higher price at IPO.
Kiromic Biopharma Inc (NASDAQ: KRBP)
Kiromic Biopharma Inc (NASDAQ: KRBP) stock is up 130% in pre-market trading after falling 10.5% in yesterday’s session.
The biopharma tech company announced it has entered into a sponsored research agreement (SRA) with Principal Investigator James W. Welsh, M.D. of The University of Texas MD Anderson Cancer Center.
Kiromic utilises its Diamond AI neural network of predictive analytics, machine learning, and artificial intelligence programming to identify the best possible cancer therapy targets using over 2 billion data points.
Over the past year, Kiromic Biopharma Inc (KRBP) has traded between $0.23 and $11. It went public via IPO a year ago.
